Lumosa Therapeutics Co., Ltd. (TPEX:6535)

Lumosa Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	252.79	235.49	425.25	516.85	840.32	898.64
Short-Term Investments	1,018	1,117	419.06	667.67	589.89	372.26
Trading Asset Securities	-	-	-	-	21.89	-
Cash & Short-Term Investments	1,270	1,353	844.31	1,185	1,452	1,271
Cash Growth	89.40%	60.23%	-28.72%	-18.43%	14.26%	103.34%
Accounts Receivable	4.77	20.63	12	14	9.69	13.84
Other Receivables	20.09	19.16	18.13	17.98	17.01	16.38
Receivables	24.87	39.79	30.14	31.98	26.7	30.22
Inventory	96.68	97.78	103.91	108.68	82.39	31.78
Prepaid Expenses	68.26	46.64	65.66	60.88	59.17	13.65
Other Current Assets	0.04	0.02	0.02	-	0.13	0.02
Total Current Assets	1,460	1,537	1,044	1,386	1,620	1,347
Property, Plant & Equipment	22.81	19.68	27.53	7.66	13	19.5
Long-Term Investments	570.83	575.42	583.79	464.72	671.32	246.72
Goodwill	-	-	-	-	-	78.49
Other Intangible Assets	0.46	0.49	0.6	26.93	43.57	92.72
Other Long-Term Assets	0.32	0.32	0.32	0.32	0.32	0.32
Total Assets	2,055	2,133	1,656	1,886	2,349	1,784
Accounts Payable	1.45	1.42	1.49	12.25	14.5	0.03
Accrued Expenses	-	36.7	54.41	33.62	43.26	28.68
Current Portion of Leases	6.82	4.2	4.49	4.33	5.4	5.83
Current Unearned Revenue	3.04	3.04	3.04	6.88	4.68	0.32
Other Current Liabilities	209.8	155.83	156.14	158.28	156.18	155.65
Total Current Liabilities	221.1	201.18	219.58	215.36	224.03	190.5
Long-Term Leases	5.2	4.28	8.12	0.36	6.08	11.13
Total Liabilities	226.31	205.46	227.69	215.72	230.11	201.63
Common Stock	1,689	1,689	1,650	1,631	1,632	1,474
Additional Paid-In Capital	2,219	2,223	1,363	1,268	1,271	963.36
Retained Earnings	-2,023	-1,919	-1,494	-1,256	-761.44	-857.38
Comprehensive Income & Other	-71.26	-81.59	-117.45	-13.53	-22.98	2.96
Total Common Equity	1,814	1,912	1,401	1,630	2,119	1,583
Minority Interest	14.62	15.84	27.89	40.18	-	-
Shareholders' Equity	1,828	1,928	1,429	1,670	2,119	1,583
Total Liabilities & Equity	2,055	2,133	1,656	1,886	2,349	1,784
Total Debt	12.02	8.48	12.61	4.69	11.49	16.95
Net Cash (Debt)	1,258	1,344	831.7	1,180	1,441	1,254
Net Cash Growth	90.90%	61.64%	-29.51%	-18.10%	14.89%	104.46%
Net Cash Per Share	7.67	8.22	5.12	7.26	9.55	10.38
Filing Date Shares Outstanding	165.37	168.9	164.97	163.1	163.15	147.37
Total Common Shares Outstanding	165.37	168.9	164.97	163.1	163.15	147.37
Working Capital	1,239	1,336	824.46	1,171	1,396	1,156
Book Value Per Share	10.97	11.32	8.49	9.99	12.99	10.74
Tangible Book Value	1,813	1,911	1,400	1,603	2,075	1,411
Tangible Book Value Per Share	10.97	11.32	8.49	9.83	12.72	9.58
Machinery	-	41.95	41.5	31.82	29.53	29.53
Leasehold Improvements	-	3.21	3.21	-	-	0.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.